Groupe ETPO Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Groupe ETPO.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Construction earnings growth9.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Zooming in on EPA:INFE's 1.2% Dividend Yield

Mar 22
Zooming in on EPA:INFE's 1.2% Dividend Yield

Compagnie Industrielle et Financière d'Entreprises (EPA:INFE) Share Prices Have Dropped 29% In The Last Three Years

Jan 27
Compagnie Industrielle et Financière d'Entreprises (EPA:INFE) Share Prices Have Dropped 29% In The Last Three Years

Something To Consider Before Buying Compagnie Industrielle et Financière d'Entreprises SA (EPA:INFE) For The 1.2% Dividend

Dec 01
Something To Consider Before Buying Compagnie Industrielle et Financière d'Entreprises SA (EPA:INFE) For The 1.2% Dividend

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Groupe ETPO has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ENXTPA:INFE - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202423501733N/A
3/31/202423911027N/A
12/31/20232421420N/A
6/30/202322631528N/A
3/31/202321541530N/A
12/31/202220551632N/A
9/30/20222108925N/A
6/30/20221988318N/A
3/31/20221947-112N/A
12/31/20211916-56N/A
9/30/20211914-66N/A
6/30/20211922-66N/A
3/31/20211811-47N/A
12/31/2020170-1-19N/A
9/30/20201650-65N/A
6/30/20201611-122N/A
3/31/20201722-105N/A
12/31/20191834-88N/A
9/30/20191824-58N/A
6/30/20191803-28N/A
3/31/20191711-18N/A
12/31/2018161-208N/A
9/30/2018158-4-15N/A
6/30/2018155-5-23N/A
3/31/2018158-4N/A1N/A
12/31/2017162-3N/A-1N/A
9/30/2017163-2N/A2N/A
6/30/20171640N/A5N/A
3/31/20171582N/A7N/A
12/31/20161535N/A10N/A
9/30/20161546N/A9N/A
6/30/20161557N/A9N/A
3/31/20161606N/A12N/A
12/31/20151655N/A15N/A
9/30/20151615N/A11N/A
6/30/20151574N/A8N/A
3/31/20151624N/A3N/A
12/31/20141674N/A-2N/A
9/30/20141765N/A-3N/A
6/30/20141855N/A-4N/A
3/31/20141835N/A3N/A
12/31/20131815N/A9N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if INFE's forecast earnings growth is above the savings rate (1.4%).

Earnings vs Market: Insufficient data to determine if INFE's earnings are forecast to grow faster than the French market

High Growth Earnings: Insufficient data to determine if INFE's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if INFE's revenue is forecast to grow faster than the French market.

High Growth Revenue: Insufficient data to determine if INFE's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if INFE's Return on Equity is forecast to be high in 3 years time


Discover growth companies